Eileen is the CCO in Examen and joined the company in September 2020 to lead the global growth of the company and commercial organization in line with the company’s strategic growth initiatives. Eileen brings 18+ years of international business leadership from emerging start-ups through to large corporate multi-nationals.
Eileen previously held a senior role in leading Dutch health tech company Philips where she led the commercial team in the Life Sciences digital pathology division. Prior to that she was a member of the leadership team at PathXL, a digital pathology software company which led to the successful acquisition by Philips in 2016. She was also a key member of the team at Belfast fin-tech startup Harco Technology which led to a successful acquisition by Wombat Financial Software in 2007, shortly followed acquisition by NYSE Technologies in 2008.
Eileen has built commercial teams and partner networks across Europe, North America and APAC markets in the life sciences, biopharma and diagnostic markets and is highly regarded for customer management – forming strong and lasting customer relationships.